Khloris Biosciences, Inc.
First-in-class targets, best-in-class vaccines
South San Francisco, United States · Founded 2022
- Headquarters
- South San Francisco, California
- Employees
- 1–10
- Founded
- 2022
- Business Model
- B2B
- Website
- khlorisbiosciences.com
About
Khloris Biosciences is a biopharmaceutical company developing first-in-class iPSC-based cancer vaccines designed to engage a multi-faceted anti-tumor immune response. The company is pioneering the use of induced pluripotent stem cells (iPSCs) as a whole-cell vaccination platform for oncology, with additional programs in iPSC-derived cardiomyocyte cell therapy for cardiovascular disease. Khloris is a spinout of technology from the Stanford Cardiovascular Institute and a Leaps by Bayer portfolio company.
Summary
Khloris Biosciences, Inc. is a Biotech company based in South San Francisco, United States, founded in 2022.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/khloris-biosciences-inc"><img src="https://indexed.vc/api/badge/company/khloris-biosciences-inc" alt="Khloris Biosciences, Inc. on Indexed.vc" width="260" height="76" /></a>